Affimed (NASDAQ: AFMD) reported Q3 EPS of (EUR0.31), EUR0.05 worse than the analyst estimate of (EUR0.26). Revenue for the quarter came in at EUR938 million versus the consensus estimate of EUR2.65 million.

For earnings history and earnings-related data on Affimed (AFMD) click here.